Global Biotechnology Instruments Market Size to Hit US$ 80,051.1 Million by 2026, with a CAGR of 12.66% Growth - Study by Facts & Factors
Facts & Factors
7 min read
[171+ Pages Research Study] According to a market research study published by Facts and Factors, the demand analysis of Global Biotechnology Instruments Market size & share revenue was estimated at approximately USD 41,006.2 Million in 2020 and is expected to reach revenue of around USD 80,051.1 Million by the end of 2026, growing at a CAGR of around 12.66% between 2021 and 2026. The key market players are listed in the report with their sales, revenues and strategies are Agilent Technologies, Becton Dickinson, and Company, Abbott, Alcon Inc., AngioDynamics, Bio-Rad Laboratories, BioMerieux SA, BioTek Instruments Inc., Cynosure LLC, Candela Medical, Endress+Hauser (Analytik Jena GmbH), Danaher Corporation, IIlumina Inc., F. Hoffmann-La Roche Ltd., IRIDEX, Merck KGaA, Lumenis, Perkin Elmer Inc., Novanta Inc., Siemens Healthineers, QIAGEN, Waters Corporation, Tecan Group AG, Zimmer Mediz
NEW YORK, United States, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Biotechnology Instruments Market Product (Lab Automation Instruments, Life Science Consumables, IVD Instruments, and Medical Lasers), and End-User (Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” in its research database.
“According to the latest research study, the demand of global Biotechnology Instruments Market size & share was valued at approximately USD 41,006.2 Million in 2020 and is likely to grow at a CAGR of 12.66% and is anticipated to reach around USD 80,051.1 Million by 2026.”
Report Overview:
Bioinstrumentation refers to the use of biomedical engineering that is focusing on the devices and mechanics, which are used in measuring, evaluating, and treating biological systems. The biotechnology instruments market across the globe has witnessed major growth in recent years, mostly due to the immense increase in demand for biotechnology products for the making of personalized medicine.
Such a promising field of medicine that aims to serve consumers via medicines produced by keeping in mind every individual’s biological makeup and getting rid of the negative effects, which might result from mass-produced medicines, is likely to be one of the key customers of biotechnology products in the forthcoming years. Moreover, the growing use of 2D and 3D cell cultures in the area of discovery and manufacture of novel drug compounds is emerging as a major aspect propelling the global biotechnology instruments market expansion.
High adoption of point-of-care diagnostic devices boost the market
The global market of biotechnology instruments is expected to grow at a significant growth rate during the forecast period. The high adoption of point-of-care diagnostic devices is a key growth factor that is driving the growth of the global biotechnology instruments market. Moreover, the huge increase in demand for biotechnology products for the production of personalized medicine is likely to propel the global market of biotechnology instruments in the upcoming years.
The high adoption of point-of-care diagnostic devices is also driving the market growth. Other factors attributing to the market growth include the continuous developments in research and developments that are improving the capabilities of point-of-care (POC) testing systems.
Rising incidence of a variety of chronic diseases globally
Besides, the rising incidence of a variety of chronic diseases worldwide, the demand for personalized medicines is anticipated to fuel the market growth during the forecast period. This, in turn, will boost market development in the coming years.
Key Insights:
Market Size & Forecast by Revenue | 2021−2026
Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
Market Segmentation – A detailed analysis by Product, by End-User, and by Region
Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Agilent Technologies, Becton Dickinson, and Company, Abbott, Alcon Inc., AngioDynamics, Bio-Rad Laboratories, BioMerieux SA, BioTek Instruments Inc., Cynosure LLC, Candela Medical, Endress+Hauser (Analytik Jena GmbH), Danaher Corporation, IIlumina Inc., F. Hoffmann-La Roche Ltd., IRIDEX, Merck KGaA, Lumenis, and others
Key Segment
By Product, By End-User, and By Region
Major Regions Covered
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options
Request customized purchase options to meet your research needs.
Segmentation Analysis
The global biotechnology instruments market has been segmented into product and end-user.
On the basis of product, the global biotechnology instruments market has been classified into lab automation instruments, life science consumables, IVD instruments, and medical lasers. In terms of the end-user industry, the global biotechnology instruments market has been bifurcated into government & academic institutes, pharmaceutical & biotechnology companies, hospitals & healthcare facilities, and others.
Geographically, the biotechnology instruments market can be segmented into North America, Asia-Pacific, Europe, the Middle East, and Africa, and Latin America.
North America is expected to contribute the largest revenue share
North America is contributing to the largest revenue share due to the increase in demand and affordability of biotechnology instruments. Moreover, the tendency to manual mechanization in the pharmaceuticals, biotechnology, and associated industries in this region is driving the demand for superior instruments for effortlessness and accelerating the process. In addition, the rising government support for research and development is also projected to enhance the regional market expansion.
The Asia-Pacific biotechnology instruments market is estimated to be the highest increasing regional market in the forthcoming years as a result of major factors such as the quick improving economy as well as the rising investments in the biotechnology segment.
Competitive Players
The major market players covered in the global biotechnology instruments market include Agilent Technologies, Becton Dickinson, and Company, Abbott, Alcon Inc., AngioDynamics, Bio-Rad Laboratories, BioMerieux SA, BioTek Instruments Inc., Cynosure LLC, Candela Medical, Endress+Hauser (Analytik Jena GmbH), Danaher Corporation, IIlumina Inc., F. Hoffmann-La Roche Ltd., IRIDEX, Merck KGaA, Lumenis, Perkin Elmer Inc., Novanta Inc., Siemens Healthineers, QIAGEN, Waters Corporation, Tecan Group AG, Zimmer MedizinSysteme GmbH, and Thermo Fisher Scientific Inc., and among others.
Browse the full “Biotechnology Instruments Market Product (Lab Automation Instruments, Life Science Consumables, IVD Instruments, and Medical Lasers), and End-User (Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” Report at https://www.fnfresearch.com/biotechnology-instruments-market
This report segments the global biotechnology instruments market as follows:
This report segments the global biotechnology instruments market as follows:
By Product
Lab Automation Instruments
Life Science Consumables
IVD Instruments
Medical Lasers
By End-User
Government & Academic Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Healthcare Facilities
Others
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Key Insights from Primary Research
According to analysis, the Biotechnology instruments market is likely to grow with a CAGR of approximately 12.66% between 2021 and 2026.
The global biotechnology instruments market was valued at around USD 41,006.2 Million in 2020 and is expected to reach USD 80,051.1 Million by 2026.
North America is projected to dominate global biotechnology instruments market growth on the basis of region.
Key Questions Answered in this Report:
What is the size of the biotechnology instruments market and what is its expected growth rate?
What are the primary driving factors that push the biotechnology instruments market forward?
What are the biotechnology instruments industry's top companies?
What are the different categories that the biotechnology instruments market caters to?
What will be the fastest-growing segment or region?
In the value chain, what role do essential players play?
What is the procedure for getting a free copy of the biotechnology instruments market sample report and company profiles?
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
